These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9010112)

  • 1. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
    Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
    Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
    Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.
    el-Naggar AK; Steck K; Batsakis JG
    Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
    Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
    Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.
    Speicher MR; Howe C; Crotty P; du Manoir S; Costa J; Ward DC
    Cancer Res; 1995 Mar; 55(5):1010-3. PubMed ID: 7866983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.